Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Simon Lowth, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below.
On 25 February 2013, Mr Lowth received an award of 11,728 shares under the AstraZeneca Deferred Bonus Plan. This award relates to the payment of his annual bonus whereby he is required to defer a portion of the bonus earned into shares for a period of three years. The shares were awarded at a price of 2939 pence per share. Mr Lowth will become beneficially entitled to these shares on 25 February 2016.
On 25 February 2013, Mr Lowth also received shares from the vesting of a previously announced award made in February 2010 under the AstraZeneca Deferred Bonus Plan whereby he has now become beneficially entitled to the shares. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
Name of Director |
Number of shares vested |
Number of shares withheld |
Net number of shares |
Market price on vesting |
Simon Lowth |
9,760 |
5,076 |
4,684 |
2952.5p |
As a result of these transactions, Mr Lowth has an interest in 298,051 Ordinary Shares, which represent approximately 0.02% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
27 February 2013